To summarize, we have shown that selective CaSR activation in human ciPTEC carrying PKD1 mutation increases intracellular calcium, reduces cAMP and mTOR activity thus reversing the principal dysregulations of the molecules considered the most proximal events in the pathogenesis of ADPKD. The gene discussed is MTOR; the disease is autosomal dominant polycystic kidney disease.